Interstitial Lung Disease News

BOSTON — Pregnant women with very severe interstitial lung disease had fewer term deliveries and more preterm births and miscarriages vs. women with a lower disease severity level, according to a presentation at the CHEST Annual Meeting.

Amy Hajari Case, MD, FCCP, has been named chief medical officer of the Pulmonary Fibrosis Foundation, according to a press release.

BOSTON — Based on patient responses, quality of life with idiopathic pulmonary fibrosis was worse among those treated in community pulmonary practices vs. interstitial lung disease centers, according to data at the CHEST Annual Meeting.

Patients with idiopathic pulmonary fibrosis had improved FVC between baseline and 12 weeks with receipt of ISM001-055, a small molecule targeting Traf2- and Nck-interacting kinase, vs. placebo, according to topline results.

BOSTON — When presented with the statement, “I have trouble keeping up with my family, friends, children and/or grandchildren because of IPF” via online survey, 49% agreed, according to a poster presented at the CHEST Annual Meeting.

Patients with rheumatoid arthritis or psoriatic arthritis starting biologic disease-modifying antirheumatic drugs have a higher risk for interstitial lung disease vs. the general population, with the highest risk found in RA, data show.

BOSTON — The odds for 30-day readmission among patients with interstitial lung disease went down if the patient was 65 years or older or a woman, according to data presented at the CHEST Annual Meeting.

BOSTON — A subspeciality clinic that combined pulmonary and palliative care improved access to these treatments for diverse and underserved populations, according to an abstract presented at the CHEST Annual Meeting.

BOSTON — Among patients with interstitial lung disease, 30% had pulmonary arterial hypertension and 20% had right ventricular hypertrophy, according to data presented at the CHEST Annual Meeting.